- Home
- TYGO vs IPSC Comparison
TYGO vs IPSC Comparison
Compare TYGO & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- IPSC
- Stock Information
- Founded
- TYGO 2007
- IPSC 2019
- Country
- TYGO United States
- IPSC United States
- Employees
- TYGO N/A
- IPSC N/A
- Industry
- TYGO Semiconductors
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- TYGO Technology
- IPSC Health Care
- Exchange
- TYGO Nasdaq
- IPSC Nasdaq
- Market Cap
- TYGO 60.2M
- IPSC 48.2M
- IPO Year
- TYGO N/A
- IPSC 2021
- Fundamental
- Price
- TYGO $1.00
- IPSC $0.54
- Analyst Decision
- TYGO Strong Buy
- IPSC Strong Buy
- Analyst Count
- TYGO 2
- IPSC 5
- Target Price
- TYGO $3.75
- IPSC $3.33
- AVG Volume (30 Days)
- TYGO 21.1K
- IPSC 719.1K
- Earning Date
- TYGO 05-06-2025
- IPSC 05-15-2025
- Dividend Yield
- TYGO N/A
- IPSC N/A
- EPS Growth
- TYGO N/A
- IPSC N/A
- EPS
- TYGO N/A
- IPSC N/A
- Revenue
- TYGO $63,051,000.00
- IPSC $114,898,000.00
- Revenue This Year
- TYGO $69.44
- IPSC $833.10
- Revenue Next Year
- TYGO $21.75
- IPSC N/A
- P/E Ratio
- TYGO N/A
- IPSC N/A
- Revenue Growth
- TYGO N/A
- IPSC 8286.72
- 52 Week Low
- TYGO $0.58
- IPSC $0.34
- 52 Week High
- TYGO $1.85
- IPSC $3.46
- Technical
- Relative Strength Index (RSI)
- TYGO 60.26
- IPSC 47.90
- Support Level
- TYGO $0.92
- IPSC $0.53
- Resistance Level
- TYGO $1.04
- IPSC $0.59
- Average True Range (ATR)
- TYGO 0.06
- IPSC 0.04
- MACD
- TYGO 0.00
- IPSC -0.00
- Stochastic Oscillator
- TYGO 75.00
- IPSC 37.56
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.